Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022

SELL
$129.64 - $160.7 $252,797 - $313,365
-1,950 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$119.87 - $145.67 $41,954 - $50,984
-350 Reduced 15.22%
1,950 $248,000
Q3 2021

Nov 12, 2021

SELL
$128.64 - $184.79 $10,419 - $14,967
-81 Reduced 3.4%
2,300 $299,000
Q2 2021

Aug 10, 2021

SELL
$160.2 - $186.42 $480 - $559
-3 Reduced 0.13%
2,381 $423,000
Q1 2021

Apr 05, 2021

SELL
$150.19 - $173.5 $3,003 - $3,470
-20 Reduced 0.83%
2,384 $392,000
Q4 2020

Feb 12, 2021

SELL
$140.71 - $165.05 $25,327 - $29,709
-180 Reduced 6.97%
2,404 $401,000
Q3 2020

Nov 09, 2020

SELL
$105.46 - $144.13 $7,382 - $10,089
-70 Reduced 2.64%
2,584 $384,000
Q2 2020

Aug 13, 2020

SELL
$95.68 - $121.88 $49,753 - $63,377
-520 Reduced 16.38%
2,654 $326,000
Q4 2019

Jan 21, 2020

SELL
$117.65 - $153.73 $1,882 - $2,459
-16 Reduced 0.5%
3,174 $479,000
Q3 2019

Nov 05, 2019

BUY
$125.18 - $143.24 $81,367 - $93,106
650 Added 25.59%
3,190 $410,000
Q1 2019

Apr 16, 2019

SELL
$121.81 - $142.95 $27,407 - $32,163
-225 Reduced 8.14%
2,540 $363,000
Q4 2018

Apr 16, 2019

BUY
$115.94 - $166.74 $320,574 - $461,036
2,765 New
2,765 $343,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Means Investment Co., Inc. Portfolio

Follow Means Investment Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Means Investment Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Means Investment Co., Inc. with notifications on news.